PDx — EBIT
GE HealthCare Technologies PDx — EBIT decreased by 15.8% to $197.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.9%, from $205.00M to $197.00M. Over 4 years (FY 2021 to FY 2025), PDx — EBIT shows an upward trend with a 5.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher EBIT indicates strong operational efficiency and profitability, while lower EBIT suggests margin erosion or operational headwinds.
Detailed definition
Earnings Before Interest and Taxes for the Pharmaceutical Diagnostics segment, representing the core operating profitabi...
Peer comparison
Standard segment operating income metric used to compare profitability across different business units in the medical technology sector.
gehc_segment_pdx_ebitHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $173.25M | $173.25M | $173.25M | $138.00M | $115.00M | $159.00M | $108.00M | $155.00M | $152.00M | $166.00M | $144.00M | $178.00M | $200.00M | $193.00M | $212.00M | $205.00M | $213.00M | $220.00M | $234.00M | $197.00M |
| QoQ Change | — | +0.0% | +0.0% | -20.3% | -16.7% | +38.3% | -32.1% | +43.5% | -1.9% | +9.2% | -13.3% | +23.6% | +12.4% | -3.5% | +9.8% | -3.3% | +3.9% | +3.3% | +6.4% | -15.8% |
| YoY Change | — | — | — | — | -33.6% | -8.2% | -37.7% | +12.3% | +32.2% | +4.4% | +33.3% | +14.8% | +31.6% | +16.3% | +47.2% | +15.2% | +6.5% | +14.0% | +10.4% | -3.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's pdx — ebit?
- GE HealthCare Technologies (GEHC) reported pdx — ebit of $197.00M in Q1 2026.
- How has GE HealthCare Technologies's pdx — ebit changed year-over-year?
- GE HealthCare Technologies's pdx — ebit decreased by 3.9% year-over-year, from $205.00M to $197.00M.
- What is the long-term trend for GE HealthCare Technologies's pdx — ebit?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's pdx — ebit has grown at a 5.9% compound annual growth rate (CAGR), from $693.00M to $872.00M.
- What does pdx — ebit mean?
- The operating profit generated by the Pharmaceutical Diagnostics segment before interest and tax expenses.